RE:what do people think of this bla filing non event ?Refiling of the BLa is a major milestone but it has been expected. Perhaps the more market moving event comes in 2 weeks when the FDA decides whether it gets priority review or not? Regardless, the key is how will the company raise enough cash to get it thru to Ryplazim commercialisation in the USA?